(Q41519406)

English

The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs).

scientific article published on February 1997

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

1 reference

Europe PubMed Central

The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs). (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

4

object named as

Auwerx J

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

author name string

Schoonjans K

2

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Fruchart JC

3

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 1997

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

79

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

2-3

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

95-99

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA POLYMORPHISM ADJACENT TO HUMAN APOPROTEIN A-1 GENE: RELATION TO HYPERTRIGLYCERIDAEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein lipase: recent contributions from molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection and characterization of the heterozygote state for lipoprotein lipase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of fibrates on lipoprotein and hemostatic coronary risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Postprandial lipemia, fenofibrate and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2897%2981497-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0300-9084(97)81497-6

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41519406&oldid=1625643180"